Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexiletine Hydrochloride for Motor Dysfunction in Spinal and Bulbar Muscular Atrophy
jRCT2041240174Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in spinal and bulbar muscular atrophy (SBMA) comparing Mexiletine with Placebo (2 arms). Primary endpoint: ALSFRS-R Score. Started Feb 2025; status: recruiting.
02
Drugs
mexiletine
03
Conditions
spinal and bulbar muscular atrophy (SBMA)
Beyond the preview
Go deeper on jRCT2041240174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041240174.